Gemcitabine-Associated Thrombotic Microangiopathy: Response to Complement Inhibition and Reinitiation of Gemcitabine

Jeffrey L. Turner, Joshua Reardon, Tanios Bekaii-Saab, Spero R. Cataland, Matthew J. Arango

Research output: Contribution to journalArticle

5 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)e119-e122
JournalClinical Colorectal Cancer
Volume16
Issue number2
DOIs
StatePublished - Jun 1 2017

Fingerprint

gemcitabine
Thrombotic Microangiopathies
Hemolytic-Uremic Syndrome
Pancreatic Neoplasms
eculizumab

Keywords

  • Drug-induced thrombotic microangiopathy
  • Eculizumab
  • Hemolytic uremic syndrome
  • Pancreatic cancer
  • Toxicity

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Gemcitabine-Associated Thrombotic Microangiopathy : Response to Complement Inhibition and Reinitiation of Gemcitabine. / Turner, Jeffrey L.; Reardon, Joshua; Bekaii-Saab, Tanios; Cataland, Spero R.; Arango, Matthew J.

In: Clinical Colorectal Cancer, Vol. 16, No. 2, 01.06.2017, p. e119-e122.

Research output: Contribution to journalArticle

Turner, Jeffrey L. ; Reardon, Joshua ; Bekaii-Saab, Tanios ; Cataland, Spero R. ; Arango, Matthew J. / Gemcitabine-Associated Thrombotic Microangiopathy : Response to Complement Inhibition and Reinitiation of Gemcitabine. In: Clinical Colorectal Cancer. 2017 ; Vol. 16, No. 2. pp. e119-e122.
@article{026c5ac81b7c486a8393950a1d4690d0,
title = "Gemcitabine-Associated Thrombotic Microangiopathy: Response to Complement Inhibition and Reinitiation of Gemcitabine",
keywords = "Drug-induced thrombotic microangiopathy, Eculizumab, Hemolytic uremic syndrome, Pancreatic cancer, Toxicity",
author = "Turner, {Jeffrey L.} and Joshua Reardon and Tanios Bekaii-Saab and Cataland, {Spero R.} and Arango, {Matthew J.}",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.clcc.2016.09.004",
language = "English (US)",
volume = "16",
pages = "e119--e122",
journal = "Clinical Colorectal Cancer",
issn = "1533-0028",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Gemcitabine-Associated Thrombotic Microangiopathy

T2 - Response to Complement Inhibition and Reinitiation of Gemcitabine

AU - Turner, Jeffrey L.

AU - Reardon, Joshua

AU - Bekaii-Saab, Tanios

AU - Cataland, Spero R.

AU - Arango, Matthew J.

PY - 2017/6/1

Y1 - 2017/6/1

KW - Drug-induced thrombotic microangiopathy

KW - Eculizumab

KW - Hemolytic uremic syndrome

KW - Pancreatic cancer

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=85002487038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85002487038&partnerID=8YFLogxK

U2 - 10.1016/j.clcc.2016.09.004

DO - 10.1016/j.clcc.2016.09.004

M3 - Article

AN - SCOPUS:85002487038

VL - 16

SP - e119-e122

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

SN - 1533-0028

IS - 2

ER -